A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DSS / disease-specific

[Related PubMed/MEDLINE]
Total Number of Papers: 79
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DSS  (>> Co-occurring Abbreviation)
Long Form:   disease-specific
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Dysregulation of ss-catenin, WISP1 and TCF21 predicts disease-specific survival and primary response against radio(chemo)therapy in patients with locally advanced squamous cell carcinomas of the head and neck. DFS
2019 FIGO Versus Silverberg Grading Systems in Ovarian Endometrioid Carcinoma: A Comparative Prognostic Analysis. DFS, FIGO, OEC
2019 Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs). DFS, PanNET, PanNETs, TAM
2018 Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas. ALDH, CSCs, EGFR, OS, STS
2018 Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer? AACCI, EC, OS
2018 Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? DFS, EGJ, GC, JGCA, LN, NAC, RCTs, SA
2018 Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance. ADT, AS, BCR, CCI, DT, HR, NCCN, OS, PCa, PSA
2018 Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes. ENE, LNs, MVA, PeCa, RFS, RT
2018 Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer. CRC, DFS
10  2018 Short- and Long-Term (10-year) Results of an Organized, Population-Based Breast Cancer Screening Program: Comparative, Observational Study from Hungary. DFS
11  2018 Survival outcomes and interval between lymphoscintigraphy and SLNB in cutaneous melanoma- findings of a large prospective cohort study. BT, CM, LS, OS, SLNB
12  2018 Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis. NELM, PSM, RFS
13  2018 Unilateral endoscopic resection with transnasal craniectomy for sinonasal intestinal-type adenocarcinoma: A bi-institutional case-control study on 54 patients. bERTC, ITAC, uERTC
14  2017 Clinicopathologic idiosyncrasies of nasopharyngeal cancer in a moderate-risk Mediterranean region. ---
15  2017 Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. HRFs, NAC, NMIBC, RC
16  2017 Influence of bone invasion on outcomes after marginal mandibulectomy in squamous cell carcinoma of the oral cavity. MM, OCSCC, PORT
17  2017 Is Older Age a Real Adverse Prognostic Factor in Women With Early-Stage Endometrial Carcinoma? A Matched Analysis. EC, LVSI, OS
18  2017 Multiple Lymph Node Basin Drainage in Trunk Melanoma Is Not Associated with Survival of Sentinel Lymph Node-Positive Patients. AJCC, CLND, DFI, LN, MLBD, SLN
19  2017 Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It. CI, MFS, STS
20  2017 Survival outcomes and patterns of failure in women with stage IIIC2 endometrial carcinoma. CRT, CT, EC, MVA, OS
21  2017 The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis. EC, LA, LUS, OS
22  2016 Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases. AC, CTL, DFS, HLA, LN, NK, SCC
23  2016 Paraaortic lymphadenectomy in intermediate to high risk uterine endometrioid cancer : a retrospective evaluation. DFS, EC, PALND, PLND
24  2016 Prognostic Significance of Solid and Micropapillary Components in Invasive Lung Adenocarcinomas Measuring ≤3 cm. DFS
25  2016 Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis. EC, OS
26  2016 Tracheal and Crico-Tracheal Resection and Anastomosis for Malignancies Involving the Thyroid Gland and the Airway. CTRA, LC, LRC, TRA
27  2016 Value of sentinel lymph node biopsy and adjuvant interferon treatment in thick (>4 mm) cutaneous melanoma: an observational study. DFS, HR, SLN
28  2015 Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. DFS, HR, RCTs
29  2015 Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients. BCa, PFS, PIWIL2
30  2015 Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study. LVSI, OS, RT
31  2015 Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. CI, DCIS, HR, IPW, OS, SEER
32  2014 Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma. OS
33  2014 Expanded criteria for carcinoid liver debulking: Maintaining survival and increasing the number of eligible patients. PFS
34  2014 Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast. ANF, NECB
35  2014 Intermediate-term oncologic outcomes of robot-assisted radical cystectomy for urothelial carcinoma. DFS, RARC, UCB
36  2014 Interval between hysterectomy and start of radiation treatment is predictive of recurrence in patients with endometrial carcinoma. OS, RT
37  2014 Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer. cT2, DFS, MIBC, PLND, RC
38  2014 No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer. AJCC, DTC, OS, PVE
39  2014 Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. CRLMs, DFS
40  2014 Survival analysis of contralateral prophylactic mastectomy: a question of selection bias. CBC, CPM, OS, SM
41  2013 DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients. DFS, IDC, SPF
42  2013 Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: No survival difference as compared to elective neck dissection. END, OS, USgFNAC
43  2013 Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. OS, PSMs
44  2013 Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma. DFS, TTV
45  2013 Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall. DFS, LPS, LRFS
46  2013 [Curative radiotherapy in patients with anal cancer: clinical outcomes and prognostic factors in a single-institution experience]. CFS, DFS, MFS
47  2012 A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival. FLO, IMRT, LRC, NPC
48  2012 Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer. MMP, VEGF
49  2012 Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma. DFS, FADD, HNSCC
50  2012 Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy. EBRT, HT, OS, PSA, RT
51  2012 Long-term survival in young women: hazards and competing risks after thyroid cancer. DTCs
52  2012 Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease. LN, MTC, ND
53  2012 p63 expression defines a lethal subset of muscle-invasive bladder cancers. EMT, OS
54  2012 Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications. LRFS, MFS, RC
55  2012 Polymorphisms in GSTM1 and XPD genes predict clinical outcome in advanced oral cancer patients treated with postoperative radiotherapy. RFS
56  2012 Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada. OS, RFS, UTUC
57  2011 Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series. DF, DMF, EPP, LRC, OS, RT
58  2011 Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. DFS, END, OSCC, SN, SNB
59  2011 The role of radical cystectomy in patients with clinical T4b bladder cancer. RFS
60  2011 Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study. CI, DFS, HR, PDECs
61  2009 Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer. APPP
62  2009 The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guerin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary? BCG, OS
63  2008 Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. DFS
64  2007 P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. RFS
65  2007 Surgical treatment of pancreatic endocrine neoplasms. DFS, PEN
66  2006 A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas. 5-FU, CI, CON, FA, LC, MMC, SEQ
67  2006 Cancer survival among adolescents in France. EFS
68  2006 E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. CI, DFS, MI
69  2006 Oropharyngeal carcinoma and its treatment in Finland between 1995-1999: a nationwide study. ND, OPC, RT
70  2005 Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. FLO, LC, OS, STP
71  2003 Adjuvant irradiation for cervical lymph node metastases from melanoma. DMFS, Gy
72  2003 Staging of advanced cervical carcinoma using MRI-predictors of outcome after radical radiotherapy. DFS, FIGO, MRI
73  2003 Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. SCC
74  2000 Early stage carcinoma of oral tongue: prognostic factors for local control and survival. DFRM, RFS, TT
75  2000 Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. DFS
76  1999 Adjuvant radiotherapy in male breast cancer. CI, DFS, OS
77  1999 Radiotherapy for invasive thymoma and thymic carcinoma. Clinicopathological review. CI, DFS, OS
78  1999 The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. LPS, MDS, PFS
79  1996 Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. AJCC, CI, MFH, MFS, RR, UICC